HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $494,663 | -31.4% | 5,810 | -36.6% | 0.01% | +10.0% |
| Q4 2022 | $720,592 | +47.7% | 9,162 | +39.0% | 0.01% | +11.1% |
| Q3 2022 | $488,000 | +49.7% | 6,589 | +31.8% | 0.01% | +12.5% |
| Q2 2022 | $326,000 | -24.0% | 5,000 | -38.1% | 0.01% | -11.1% |
| Q4 2021 | $429,000 | -65.9% | 8,080 | -57.2% | 0.01% | -70.0% |
| Q2 2021 | $1,259,000 | +145.4% | 18,889 | +308.7% | 0.03% | +50.0% |
| Q1 2021 | $513,000 | – | 4,622 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |